Cyprus Mail on MSN
New AI tools to make European businesses more competitive
Europe’s business environment is entering a new phase of digital maturity. For years, commentators have argued that companies across the continent move more cautiously than their counterparts in the ...
Elon explicitly pushed back on today’s Business Insider “Macrohard stalled → pivot to Tesla” FUD. XAI minor staff churn, ...
Celonis evangelist Rudy Kuhn argues that without process intelligence, AI agents are flying blind - and that composability, not another three-year transformation program, is the real key to enterprise ...
"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...
It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.
UiPath (PATH) stock slides after Q4 FY26 results as Needham upgrades to Buy on ARR and free cash flow growth; AI ARR hits $200M.
UiPath Inc PATH reported financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. Here’s a look at the key details from the report. UiPath shares are advancing ...
Zacks Investment Research on MSN
UiPath's AI automation model is driving platform-level efficiency
UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...
UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year revenue growth.
UiPath Inc. beat expectations on earnings and revenue in its latest financial results, doubled its profitability and offered ...
Stocktwits on MSN
UiPath’s AI automation story is not translating into faster growth yet, say UBS, Morgan Stanley analysts
Morgan Stanley analyst Sanjit Singh also trimmed his price target to $17 from $19. ・Analysts say fourth-quarter results met expectations but see limited near-term upside due to modest growth. ・UBS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results